Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Stroke Cerebrovasc Dis ; 27(3): 816-818, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29107634

RESUMEN

Although intracranial arterial calcifications (IACs) are encountered in approximately 85% of patients with acute ischemic stroke (IS), the significance of IAC in plaque instability is still controversial. Because most tissues including brain tissue have vitamin D receptors, vitamin D deficiency might play multiple roles in variable sites. Here, we report a novel presentation of IS with IAC including anterior cerebral artery involvement due to vitamin D deficiency. In conclusion, although the role of IAC in cerebral infarction is still controversial, we suggest that insufficient vitamin D should be examined and treated appropriately in all patients with IS. We believe that this article provides important implications for the treatment of vitamin D deficiency in patients with IS.


Asunto(s)
Isquemia Encefálica/etiología , Enfermedades Arteriales Intracraneales/etiología , Accidente Cerebrovascular/etiología , Calcificación Vascular/etiología , Deficiencia de Vitamina D/complicaciones , Biomarcadores/sangre , Isquemia Encefálica/diagnóstico por imagen , Suplementos Dietéticos , Imagen de Difusión por Resonancia Magnética , Femenino , Humanos , Enfermedades Arteriales Intracraneales/diagnóstico por imagen , Persona de Mediana Edad , Factores de Riesgo , Accidente Cerebrovascular/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Calcificación Vascular/diagnóstico por imagen , Vitamina D/análogos & derivados , Vitamina D/sangre , Vitamina D/uso terapéutico , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/diagnóstico , Deficiencia de Vitamina D/tratamiento farmacológico
2.
Carbohydr Polym ; 151: 274-282, 2016 Oct 20.
Artículo en Inglés | MEDLINE | ID: mdl-27474568

RESUMEN

Normal maize starch was subjected to heat-moisture treatment (HMT) under mildly acidic conditions (0.000, 0.050, or 0.075M H2SO4) for various treatment times (3, 5, or 8h) followed by homogenization up to 60min to prepare nanoparticles. The combination of HMT (0.075M, for 8h) and homogenization (60min) produced nanoparticles with diameters of less than 50nm at a yield higher than 80%. X-ray diffractometry and size-exclusion chromatography revealed that HMT under mildly acidic conditions selectively hydrolyzed the starch chains (especially amylose and/or long chains of amylopectin) in the amorphous region of the granules without significant damage to the crystalline structure, however, modification of the molecular structure in the amorphous region increased fragility of the granules during homogenization. Homogenization for 60min caused obvious damage in the long-range crystalline structure of the HMT starch (0.15N, for 8h), while the short-range chain associations (FT-IR) remained intact.


Asunto(s)
Nanopartículas/química , Almidón , Calor , Estructura Molecular , Agua/química , Zea mays/química
3.
Biosci Biotechnol Biochem ; 79(10): 1644-53, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25971153

RESUMEN

Sulfated polysaccharides (SP) isolated from freshwater green algae, Spirogyra neglecta (Hassall) Kützing, and fractionated SPs were examined to investigate their molecular characteristics and immunomodulatory activity. The crude and fractionated SPs (F1, F2, and F3) consisted mostly of carbohydrates (68.5-85.3%), uronic acids (3.2-4.9%), and sulfates (2.2-12.2%) with various amounts of proteins (2.6-17.1%). D-galactose (23.5-27.3%), D-glucose (11.5-24.8%), L-fucose (19.0-26.7%), and L-rhamnose (16.4-18.3%) were the major monosaccharide units of these SPs with different levels of L-arabinose (3.0-9.4%), D-xylose (4.6-9.8%), and D-mannose (0.4-2.3%). The SPs contained two sub-fractions with molecular weights (Mw) ranging from 164 × 10(3) to 1460 × 10(3) g/mol. The crude and fractionated SPs strongly stimulated murine macrophages, producing considerable amounts of nitric oxide and various cytokines via up-regulation of their mRNA expression by activation of nuclear factor-kappa B and mitogen-activated protein kinases pathways. The main backbone of the most immunoenhancing SP was (1→3)-L-Fucopyranoside, (1→4,6)-D-Glucopyranoside, and (1→4)-D-Galactopyranoside.


Asunto(s)
Citocinas/agonistas , Factores Inmunológicos/química , Macrófagos/efectos de los fármacos , Polisacáridos/química , Spirogyra/química , Proteínas Algáceas/química , Proteínas Algáceas/aislamiento & purificación , Animales , Arabinosa/química , Línea Celular , Citocinas/genética , Citocinas/inmunología , Fucosa/química , Galactosa/química , Regulación de la Expresión Génica , Glucosa/química , Glucósidos/química , Factores Inmunológicos/aislamiento & purificación , Factores Inmunológicos/farmacología , Macrófagos/citología , Macrófagos/inmunología , Manosa/química , Ratones , Proteínas Quinasas Activadas por Mitógenos/genética , Proteínas Quinasas Activadas por Mitógenos/inmunología , FN-kappa B/agonistas , FN-kappa B/genética , FN-kappa B/inmunología , Óxido Nítrico/biosíntesis , Óxido Nítrico/inmunología , Extractos Vegetales/química , Polisacáridos/aislamiento & purificación , Polisacáridos/farmacología , Ramnosa/química , Sulfatos/química , Ácidos Urónicos/química , Ácidos Urónicos/aislamiento & purificación , Xilosa/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA